The MSI-20 Score Provides Reproducible Mortality Risk Stratification in Spinal Infection: A Multicenter Registry Study and External Validation
Neurospine · 31.07.2026 · 23 (3) · 625-632
DOI: 10.14245/ns.26520814.0407 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurospine, erschienen am 31.07.2026. Verfasst von Sara Lener und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria. sara.lener@i-med.ac.at. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
Spinal infection (SI) is associated with substantial morbidity and mortality, and optimal treatment strategies remain debated, particularly in medically fragile patients. The Mortality in Spinal Infection (MSI-20) score was developed as the first dedicated prognostic tool for mortality risk estimation, but external validation in large cohorts has been lacking. This study aimed to externally validate the MSI-20 in a large multicenter registry cohort and assess its performance, clinical thresholds, and generalizability.
Methods
This retrospective multi-institutional registry study included 1,122 adult patients with clinically, radiologically, and laboratory-confirmed SI treated at 6 tertiary referral centers between 2010 and 2023. The multicenter registry design enabled robust analysis of this relatively rare outcome. MSI-20 scores were calculated according to the original definition. Predictive performance was evaluated using receiver operating characteristic (ROC) analysis with 95% confidence intervals. Mortality across score strata and center-wise performance were analyzed, with exploratory assessment of additional baseline predictors.
Results
Mean age was 66.4±13.1 years, and overall mortality was 18.3%. The MSI-20 demonstrated fair discriminative ability (area under the curve [AUC], 0.68; 95% confidence interval [CI], 64–72). The optimal ROC threshold was 3.5; a cutoff ≥4 yielded sensitivity 0.49 and specificity 0.74 (F1 score, 0.38). Mortality increased progressively, approaching 50% (47.4%) at scores ≥9. Performance was consistent across centers (AUC, 0.60–0.75). Exploratory univariable analyses did not identify additional baseline variables with consistent strong associations beyond the MSI-20 components.
Conclusion
This large multicenter registry study provides the first external validation of the MSI-20, confirming reproducibility and generalizability. The score demonstrated fair discrimination and a clear risk gradient across increasing score categories. Given its simplicity and high negative predictive value, the MSI-20 may serve as an adjunctive tool to support risk communication, multidisciplinary discussion, patient counseling, and preoperative optimization in spinal infection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria. sara.lener@i-med.ac.at.
- Department of Neurosurgery, Medical University of Innsbruck, Innsbruck, Austria.
- Department of Neurosurgery and Neurology, Spine Center Innsbruck (WIK), Sanatorium Kettenbrücke, Innsbruck, Austria.
- Machine Intelligence in Clinical Neuroscience and Microsurgical Neuroanatomy (MICN) Laboratory, Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, Switzer…
- Department of Neurosurgery, Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Germany.
- Department of Neurosurgery, Klinikum Dortmund Hospital, Dortmund, Germany.
Zitieren
APA
Lener, S., Gmeiner, R., Abramovic, A., Koller, A., Orban, C., Hartmann, S., Grob, A., Staartjes, V., Joerger, A. K., Albrecht, C., Meyer, B., Lange, F., Kramer, A., Ringel, F., Jesse, C. M., Schär, R. T., Bettag, C., Rohde, V., Janssen, I. K., …, & Thomé, C. (2026). The MSI-20 Score Provides Reproducible Mortality Risk Stratification in Spinal Infection: A Multicenter Registry Study and External Validation. Neurospine, 23(3), 625-632. https://doi.org/10.14245/ns.26520814.0407
Vancouver
Lener S, Gmeiner R, Abramovic A, Koller A, Orban C, Hartmann S, et al. The MSI-20 Score Provides Reproducible Mortality Risk Stratification in Spinal Infection: A Multicenter Registry Study and External Validation. Neurospine. 2026;23(3):625-632. doi:10.14245/ns.26520814.0407
BibTeX
@article{Lener2026,
author = {Lener, Sara and Gmeiner, Raphael and Abramovic, Anto and Koller, Anna and Orban, Christoph and Hartmann, Sebastian and Grob, Alexandra and Staartjes, Victor and Joerger, Ann Kathrin and Albrecht, Carolin and Meyer, Bernhard and Lange, Felipa and Kramer, Andreas and Ringel, Florian and Jesse, Christopher Marvin and Schär, Ralph T and Bettag, Christoph and Rohde, Veit and Janssen, Insa K and Schaller, Karl and Onken, Julia and Sanchin, Aminaa and Vajkoczy, Peter and Shah, Imran and Sutherland, Rebecca and Demetriades, Andreas K and Thomé, Claudius},
title = {The MSI-20 Score Provides Reproducible Mortality Risk Stratification in Spinal Infection: A Multicenter Registry Study and External Validation},
journal = {Neurospine},
year = {2026},
volume = {23},
number = {3},
pages = {625--632},
doi = {10.14245/ns.26520814.0407}
}
EUVIMED